
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2026-04-02 | Lynx1 Capital Management LP | 10% Owner | Purchase | 520 | $10.60 | $6K | 1.54M | View ↗ | |
| 2026-03-10 | 2026-03-12 | Yang Rick | 10% Owner | Purchase | 207.1K | $11.11 | $2.30M | 1.30M | View ↗ |
No annual data found.
Korro to Present at the 2026 Jefferies Global Healthcare Conference
Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update